ISSN:
0803-7051
eISSN:
1651-1999
Dyscypliny:
- inżynieria biomedyczna (Dziedzina nauk inżynieryjno-technicznych)
- biologia medyczna (Dziedzina nauk medycznych i nauk o zdrowiu)
- nauki farmaceutyczne (Dziedzina nauk medycznych i nauk o zdrowiu)
- nauki medyczne (Dziedzina nauk medycznych i nauk o zdrowiu)
- nauki o zdrowiu (Dziedzina nauk medycznych i nauk o zdrowiu)
- biotechnologia (Dziedzina nauk ścisłych i przyrodniczych)
Punkty Ministerialne: Pomoc
Rok | Punkty | Lista |
---|---|---|
Rok 2024 | 70 | Ministerialna lista czasopism punktowanych 2024 |
Rok | Punkty | Lista |
---|---|---|
2024 | 70 | Ministerialna lista czasopism punktowanych 2024 |
2023 | 70 | Lista ministerialna czasopism punktowanych 2023 |
2022 | 70 | Lista ministerialna czasopism punktowanych (2019-2022) |
2021 | 70 | Lista ministerialna czasopism punktowanych (2019-2022) |
2020 | 70 | Lista ministerialna czasopism punktowanych (2019-2022) |
2019 | 70 | Lista ministerialna czasopism punktowanych (2019-2022) |
2018 | 20 | A |
2017 | 20 | A |
2016 | 20 | A |
2015 | 15 | A |
2014 | 20 | A |
2013 | 20 | A |
2012 | 20 | A |
2011 | 20 | A |
2010 | 20 | A |
Model czasopisma:
Open Access
Punkty CiteScore:
Rok | Punkty |
---|---|
Rok 2022 | 3 |
Rok | Punkty |
---|---|
2022 | 3 |
2021 | 3.5 |
2020 | 3.4 |
2019 | 4 |
2018 | 3.7 |
2017 | 4.4 |
2016 | 4 |
2015 | 3.4 |
2014 | 3.4 |
2013 | 3.3 |
2012 | 2.8 |
2011 | 2.8 |
Impact Factor:
Zaloguj się aby zobaczyć Współczynnik Impact Factor dla tego czasopisma
Sherpa Romeo:
Prace opublikowane w tym czasopiśmie
Filtry
wszystkich: 110
Katalog Czasopism
-
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited
Publikacja -
Masked arterial hypertension in a 64-year-old man with primary aldosteronism
Publikacja -
Women’s health, cardiovascular risk and hypertension: the perspective still needs to improve
Publikacja -
Novel approaches: targeting sympathetic outflow in the carotid sinus
Publikacja -
Peter Meredith
Publikacja -
The Health Outcomes Prevention and Evaluation 4 (HOPE 4) project: A successful community-based intervention to lower cardiovascular risk in people with hypertension
Publikacja -
The PARAGON-Heart failure trial – another disappointment for heart failure patients with hypertension and preserved ejection fraction
Publikacja -
Blood Pressure in 2016: increased impact factor and change of editors
Publikacja -
Revisiting the pre-hypertension debate: Increasing evidence for treatment – or not?
Publikacja -
High mortality explained by mildly elevated blood pressure in Scandinavian adolescent conscripts – A plea for early drug treatment?
Publikacja -
Implementation of 24-hour Blood Pressure Control
Publikacja -
Primary cardiovascular prevention by Mediterranean diet – The PREDIMED trial
Publikacja -
An appropriate SCORE to assess cardiovascular risk in hypertension?
Publikacja -
Treatment of high blood pressure in acute stroke – The SCAST Study
Publikacja -
Documentation of endpoint prevention with combination therapy in hypertension is urgently needed
Publikacja -
The question of whether diabetes and its cardiovascular risks can be prevented: A realistic DREAM?
Publikacja -
Cardiovascular risks in HIV patients
Publikacja -
ASCOT – More than a horse race!
Publikacja -
The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension
Publikacja -
Does GISSI-AF change the concept of using RAS inhibitors in the primary prevention of atrial fibrillation in hypertensive patients?
Publikacja -
Ambulatory Blood Pressure Adds to Explaining Benefits of AT‐1 Receptor Blockade in the Treatment of Left Ventricular Hypertrophy
Publikacja -
Increased time varying heart rate and cardiovascular risk in hypertension – Benefit of selective I(f)channel inhibitor?
Publikacja -
Direct renin inhibitors in hypertension – Approaching the moment of truth
Publikacja -
Benefits of hypertension management in diabetes: An opportunity not to be missed
Publikacja -
Combination treatment in hypertension – the latest 2013 European Guidelines
Publikacja -
Hypertension Management by Practice Guidelines
Publikacja -
Hypertension research into the new millennium
Publikacja -
Blood Pressure celebrates 20 years of dedication to Nordic hypertension research
Publikacja -
Supine blood pressure normalised by daytime series values is independently associated with ischaemic wake-up stroke
Publikacja -
Antihypertensive therapy and cancer risks?
Publikacja -
Cost‐effectiveness of blood pressure measurement and hypertension follow‐up
Publikacja -
More is Less? Optimal Combination Therapy for Adequate Blood Pressure Lowering in Hypertension
Publikacja -
ESH statement on detection and punishment of abstract fraud and poster plagiarism
Publikacja -
Medical decision making in hypertension
Publikacja -
Daytime, home and office blood pressures in treated hypertensive patients according to accretion of cardiovascular risk
Publikacja -
RAAS inhibition – a practice of medical progress
Publikacja -
Angiotensin receptor blockers and cancer – Relationship dismissed by VALUE data while waiting for EMA and FDA reports
Publikacja -
Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials
Publikacja -
Renal denervation in hypertension: is it the end or the beginning of a SPYRAL?
Publikacja -
The INTERSALT Study and the complex relationship between salt intake and blood pressure
Publikacja -
Angiotensin receptor blockers and endpoint protection
Publikacja -
Blood pressure control – Slowly getting there through new strategies?
Publikacja -
Hypertension and coronary artery disease: Mechanistic insights and therapeutic challenges
Publikacja -
EDITORIALHypertension and cardiovascular disease: Is arterial stiffness the heart of the matter?
Publikacja -
Blood pressure variability: Emerging role in risk assessment and therapeutics
Publikacja -
Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure
Publikacja -
Urgent need to address quality control issues of out‐of‐office blood pressure measurement and patient risk assessment
Publikacja -
Survey of patient and physician assessment of a compliance reminder device in the treatment of hypertension
Publikacja -
The PARAGON Heart Failure trial – ongoing investigation of the angiotensin receptor antagonist/neprilysin inhibitor sacubitril/valsartan in heart failure patients with hypertension and preserved ejection fraction
Publikacja -
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension
Publikacja
wyświetlono 86 razy